Comments on: Biovex agrees to Special Protocol Assessment (SPA) with the FDA for a pivotal phase III study with Oncovexin head and neck cancer

Comments on: Biovex agrees to Special Protocol Assessment (SPA) with the FDA for a pivotal phase III study with Oncovexin head and neck cancer http://oralcancernews.org/wp/biovex-agrees-to-special-protocol-assessment-spa-with-the-fda-for-a-pivotal-phase-iii-study-with-oncovexin-head-and-neck-cancer/ The Oral Cancer Foundation News Archive Thu, 08 Jul 2010 20:11:52 +0000 http://wordpress.org/?v=2.9.2 hourly 1